Diego Salas-Benito

9PUBLICATIONS
76CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 18, 2025
CAR-T cell therapy targeting MUC17 in gastric tumors.

Sangwoo Park, Cassidy E Ho, Filippo Birocchi

|Nov 13, 2025
Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer.

Alexander Armstrong, Graziella van der Plancke, Sae Nishiguchi

|Sep 10, 2025
Tandem CAR-T cells targeting mesothelin and MUC16 overcome tumor heterogeneity by targeting one antigen at a time.

Diego Salas-Benito, Filippo Birocchi, Sangwoo Park

|Jun 04, 2025
IFN-γ-resistant CD28 CAR T cells demonstrate increased survival, efficacy, and durability in multiple murine tumor models.

Stefanie R Bailey, Hana N Takei, Giulia Escobar

|Jun 02, 2025
Secretion of a VEGF-Blocking scFv Enhances CAR T-cell Potency.

Valentina M Supper, Hannah Donner, Filippo Birocchi

|Jun 05, 2024
Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics.

Felix Korell, Michael L Olson, Diego Salas-Benito

Pageof 2

Frequent Collaborators

7 joint publications

Marcela V Maus

6 joint publications

Trisha R Berger

6 joint publications

Mark B Leick

6 joint publications

Filippo Birocchi